ACR Appropriateness Criteria Myelopathy.

Published

Journal Article

Patients presenting with myelopathic symptoms may have a number of causative intradural and extradural etiologies, including disc degenerative diseases, spinal masses, infectious or inflammatory processes, vascular compromise, and vertebral fracture. Patients may present acutely or insidiously and may progress toward long-term paralysis if not treated promptly and effectively. Noncontrast CT is the most appropriate first examination in acute trauma cases to diagnose vertebral fracture as the cause of acute myelopathy. In most nontraumatic cases, MRI is the modality of choice to evaluate the location, severity, and causative etiology of spinal cord myelopathy, and predicts which patients may benefit from surgery. Myelopathy from spinal stenosis and spinal osteoarthritis is best confirmed without MRI intravenous contrast. Many other myelopathic conditions are more easily visualized after contrast administration. Imaging performed should be limited to the appropriate spinal levels, based on history, physical examination, and clinical judgment. The ACR Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed every three years by a multidisciplinary expert panel. The guideline development and review include an extensive analysis of current medical literature from peer-reviewed journals, and the application of a well-established consensus methodology (modified Delphi) to rate the appropriateness of imaging and treatment procedures by the panel. In those instances in which evidence is lacking or not definitive, expert opinion may be used to recommend imaging or treatment.

Full Text

Duke Authors

Cited Authors

  • Roth, CJ; Angevine, PD; Aulino, JM; Berger, KL; Choudhri, AF; Fries, IB; Holly, LT; Kendi, ATK; Kessler, MM; Kirsch, CF; Luttrull, MD; Mechtler, LL; O'Toole, JE; Sharma, A; Shetty, VS; West, OC; Cornelius, RS; Bykowski, J

Published Date

  • January 2016

Published In

Volume / Issue

  • 13 / 1

Start / End Page

  • 38 - 44

PubMed ID

  • 26653797

Pubmed Central ID

  • 26653797

Electronic International Standard Serial Number (EISSN)

  • 1558-349X

Digital Object Identifier (DOI)

  • 10.1016/j.jacr.2015.10.004

Language

  • eng

Conference Location

  • United States